Onkologicum HOPA MVZ GmbH

What Onkologicum HOPA MVZ GmbH does

Onkologicum HOPA MVZ GmbH is a small outpatient oncology medical care center (Medizinisches Versorgungszentrum, or MVZ) headquartered in Hamburg, Germany, that has operated under its current form since 1976. The name "Onkologicum" and the MVZ legal designation indicate a physician-led outpatient facility focused on the diagnosis, treatment, and ongoing care of cancer patients within the German statutory and private healthcare reimbursement system (GKV/PKV, settled under EBM and GOÄ fee schedules). With approximately 15 employees based at a single Hamburg site (hopa.de), the practice operates at a small, single-location scale typical of a community oncology MVZ rather than a hospital-affiliated or multi-site network.

The company's underlying technology, core products, and service mix are not documented in the captured source material. The firm's own website returned only a verification/redirect page with no substantive product, clinical-program, or technology content, and no pricing, payer-contract, or service-line details are available. Based on the firmographic footprint alone, the business model is reimbursement-driven: revenues are earned by delivering outpatient oncology consultations, diagnostics, infusion/therapy, and follow-up visits that are billed to German health insurers on a per-case and per-procedure basis. There is no evidence of consumer-facing products, software, ancillary services, or non-clinical revenue streams.

There are no documented strategic moves, funding events, partnerships, leadership changes, M&A activity, expansion signals, or AI/technology investments in the input data. Consequently, the assessment of competitive positioning, growth trajectory, and AI capability rests almost entirely on the inferred profile of a mature, single-site Hamburg oncology MVZ, with material data gaps on clinical scope, payer mix, referral base, and financial performance.

Name

Onkologicum HOPA MVZ GmbH

Website

https://hopa.de

Company type

Private

Headcount range

11–50 employees

Short description

Onkologicum HOPA MVZ GmbH is a small, single-site outpatient oncology medical care center (MVZ) in Hamburg, Germany, founded in 1976 and staffed by approximately 15 employees, delivering community-level cancer diagnosis and treatment services to local patients under the German statutory and private reimbursement system.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Medical Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Oncology medical services
• Hematology care
• Cancer treatment
• Medical care center
• Outpatient oncology

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Others

Core offering

Onkologicum HOPA MVZ GmbH is a Hamburg-based German Medizinisches Versorgungszentrum (MVZ) — a Medical Care Center — providing outpatient specialist services in hematology and oncology. Founded in 1976 with roughly 15 employees, the practice delivers cancer- and blood-disease-related consultations, diagnostics, and treatments to individual patients in the Hamburg region.

Differentiator

Problem solved

Functional benefit

Products and services

• Hematology and Oncology Outpatient Care Outpatient specialist consultations, diagnostics, and treatment for patients with oncologic and hematologic conditions, delivered at a Medizinisches Versorgungszentrum (Medical Care Center) in Hamburg, Germany. Targeted at individual patients referred from primary care or other specialists in the Hamburg region.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Broad incumbents

• Asklepios Kliniken: One of Germany's largest private hospital operators with significant oncology programs, including Asklepios Klinik Hamburg locations. Comparable because it delivers oncology services in the same Hamburg market under broader inpatient/outpatient portfolio.
• Schoen Klinik SE: German private hospital chain offering specialty care including oncology programs. Comparable as a multi-site specialty provider operating in similar reimbursement and competitive dynamics.
• Helios Kliniken: Fresenius-owned hospital chain with oncology departments across Germany including Hamburg-area sites. Comparable as a large incumbent offering oncology care as part of a multi-specialty hospital portfolio.
• Medicover: European healthcare operator running outpatient clinics and specialty care centers, including oncology services across Germany/Central Europe. Comparable because it operates specialist ambulatory clinics at greater scale in similar markets.
• ATOS Kliniken: German specialty hospital group focused on orthopedic and surgical specialties, with growing oncology-adjacent services. Comparable as a private specialty hospital operator navigating the same German payer environment.
• Sana Kliniken AG: Private German hospital group with oncology services and outpatient centers. Comparable because it operates specialist cancer care alongside broader hospital services and competes for the same referring physician base.
• University Medical Center Hamburg-Eppendorf (UKE): Major academic medical center in Hamburg with a comprehensive hematology/oncology program. Comparable because it draws the same patient population for specialty oncology care in the same Hamburg geography, particularly for complex cases.
• GenesisCare: International specialist oncology provider operating cancer treatment centers across multiple geographies. Comparable because it focuses on outpatient/community oncology delivery in a specialist practice model similar to an oncology MVZ.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/hopa-struenseehaus

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onkologicum HOPA MVZ GmbH